CHANTELLE JOHNSON: Open Payments
NPI 1154081131 · HOMESTEAD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$891 in 38 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $891
Food & beverage: $821Education: $70
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $264 |
| Astellas Pharma US Inc | 3 | $137 |
| Lilly USA, LLC | 9 | $123 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $87 |
| Sumitomo Pharma America, Inc. | 3 | $71 |
| PFIZER INC. | 2 | $56 |
| Dexcom, Inc. | 2 | $33 |
| Eisai Inc. | 1 | $32 |
| Insmed, Inc. | 1 | $25 |
| Paratek Pharmaceuticals, Inc. | 1 | $24 |
Products named: MOUNJARO, Kerendia, FARXIGA, GEMTESA, Veozah, ELIQUIS, Dexcom G6 Transmitter, Leqembi.
Industry payments across FL — which companies pay providers there.
